Saamya Biotech IPO which closes for subscription today, seems to be performing very well. Since Saamya Bio IPO is a fixed price IPO the exact subscription details are not known. However, interacting with a few brokers here in Mumbai, I was told that there is heavy demand for the Saamya Biotech IPO. Infact the brokers are now facing shortage of IPO application forms due to the unexpected demand for the Saamya Biotech India Limited IPO. Looks like Saamya Biotech IPO will provide excellent listing gains. However, since the Saamya Biotech IPO is a fixed price IPO, investors should be preprared to wait for 30 days to get allotment and refund. The listing price of Saamya Biotech IPO will depend on the market conditions at the time of listing. Those investors who are looking at a medium risk, high returns investment opportunity can look at investing in the Saamya Biotech IPO for listing gains.